IOMX Trademark

Trademark Overview


On Monday, February 19, 2018, a trademark application was filed for IOMX with the United States Patent and Trademark Office. The USPTO has given the IOMX trademark a serial number of 87802718. The federal status of this trademark filing is REGISTERED as of Tuesday, January 5, 2021. This trademark is owned by IOmx Therapeutics AG. The IOMX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Scientific services, namely, scientific research, analysis and testing in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Scientific services, namely, scientific research, analysis and testing in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, as well as for controlling and managing patient medical information, with any of the aforementioned services for use in the fields of biology, chemistry or medicine, as well as for use in the fields of i...

Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for use in the treatment or prevention of complications associated wi...

Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, s...
iomx

General Information


Serial Number87802718
Word MarkIOMX
Filing DateMonday, February 19, 2018
Status700 - REGISTERED
Status DateTuesday, January 5, 2021
Registration Number6236118
Registration DateTuesday, January 5, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements


Goods and ServicesScientific services, namely, scientific research, analysis and testing in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Scientific services, namely, scientific research, analysis and testing in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, as well as for controlling and managing patient medical information, with any of the aforementioned services for use in the fields of biology, chemistry or medicine, as well as for use in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry; Design and development of computer software for database management, cloud-storage of data, data-management, data-query, data-analysis and data-presentation, as well as for the query, analysis and presentation of the sequence or structure of molecules, or for predicting or providing a medical diagnosis or prognosis, with any of the aforementioned services for use in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations and biomarker reagents, and diagnostic apparatus
Goods and ServicesPharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Pharmaceuticals, medical and veterinary preparations, pharmaceutical preparations and formulations, and medicated health preparations, all of the aforesaid goods for use in the treatment or prevention of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for use in the treatment or prevention of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions; Diagnostic preparations and biomarker reagents for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions
Goods and ServicesDiagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, pulmonary, musculoskeletal, lymphatic or gastrointestinal diseases, disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, bone sensory, viral, urinary, renal, metabolic or central nervous system diseases disorders and conditions, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit; Diagnostic apparatus for the diagnosis or prognosis of human and animal diseases, disorders and conditions, namely, infectious, auto-immune or immune-related, cell-proliferative or oncologic diseases, disorders and conditions, cancers, tumours and metastases, and for the diagnosis or prognosis of complications associated with such diseases, disorders and conditions, specifically, sample-analysis devices and related data-analysis software sold as a unit, nucleic acid-analysis or protein-analysis diagnosis apparatus, and diagnostic apparatus utilizing a diagnostic or prognosis algorithm and related algorithm software sold as a unit

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 26, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIOmx Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPlanegg/Martinsried 82152
DE

Party NameIOmx Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPlanegg/Martinsried 82152
DE

Party NameIOmx Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPlanegg/Martinsried 82152
DE

Trademark Events


Event DateEvent Description
Thursday, February 22, 2018NEW APPLICATION ENTERED
Monday, February 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 16, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 30, 2018ASSIGNED TO LIE
Tuesday, April 3, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 4, 2018ASSIGNED TO EXAMINER
Monday, June 4, 2018NON-FINAL ACTION WRITTEN
Monday, June 4, 2018NON-FINAL ACTION E-MAILED
Monday, June 4, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 12, 2018SUSPENSION LETTER WRITTEN
Wednesday, December 12, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, December 12, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 18, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 18, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 24, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, July 9, 2020FINAL REFUSAL WRITTEN
Thursday, July 9, 2020FINAL REFUSAL E-MAILED
Thursday, July 9, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 24, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 11, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, September 15, 2020ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021REGISTERED-PRINCIPAL REGISTER
Friday, October 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 8, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 8, 2021TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, October 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 6, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, February 8, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 5, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED